SHBG (Extended): Normal Reference Ranges vs. Functional Optimal Levels

What Does "SHBG (Extended)" Mean on a Lab Order?

An SHBG (extended) panel goes beyond the single SHBG value. It bundles SHBG with total testosterone, albumin, and a calculated free testosterone, giving clinicians the inputs they need to assess bioavailable hormone status in one draw. The "extended" designation is a lab-reporting convention, not a separate analyte.

SHBG is a glycoprotein synthesized primarily by the liver 1. It binds circulating sex steroids with high affinity: dihydrotestosterone (DHT) binds most tightly, followed by testosterone, then estradiol 2. Only the unbound fraction (roughly 2 to 3% of total testosterone in men) is considered biologically active at the receptor level. A second loosely bound fraction attached to albumin is also bioavailable because albumin releases hormones quickly in capillary beds.

This matters clinically. Two men can share a total testosterone of 500 ng/dL yet have very different symptom profiles if one carries an SHBG of 20 nmol/L and the other 65 nmol/L. The first has substantially more free testosterone available to tissues. The second may present with fatigue, low libido, or poor recovery despite a "normal" total T. Without the SHBG context, the total testosterone number is incomplete.

The Endocrine Society's 2018 clinical practice guideline for male hypogonadism recommends measuring SHBG whenever total testosterone falls in the borderline range (264 to 400 ng/dL) to avoid misclassification 3. The guideline specifically states: "Calculated free testosterone or bioavailable testosterone should be used to confirm the diagnosis in men with total testosterone near the lower limit of normal and in whom alterations in SHBG are suspected."

Standard Lab Reference Ranges and Why They Are So Wide

Most commercial laboratories report male SHBG at 10, 80 nmol/L and female SHBG at 18, 144 nmol/L. These ranges capture roughly the 2.5th to 97.5th percentile of the assayed population. They tell you whether a value is statistically unusual. They do not tell you whether it is clinically optimal.

The width reflects real biological variance. SHBG concentrations shift with age (rising approximately 1.6% per year in men after 40) 4, body composition, thyroid status, insulin sensitivity, liver health, and exogenous hormone use. A 2012 cross-sectional analysis of 3,156 men in the European Male Ageing Study found SHBG ranged from 15 to over 100 nmol/L in healthy men aged 40, 79, with BMI and insulin resistance explaining the largest share of variance 5.

Oral contraceptives can double or triple SHBG in women 6. A woman on a combined oral contraceptive pill with an SHBG of 120 nmol/L is not pathological. She is pharmacologically expected. But a woman not on hormonal contraception at the same level deserves evaluation for hyperthyroidism, hepatic pathology, or anorexia. Context collapses the reference range into a much narrower interpretive window.

Functional Optimal Ranges: Where Clinicians Draw Tighter Lines

Functional and integrative practitioners use narrower SHBG targets derived from symptom-resolution data, free-hormone calculations, and clinical experience rather than population statistics alone. These are not formal guideline thresholds. They represent the zone where bioavailable hormone levels tend to align with symptom improvement.

For men receiving testosterone replacement therapy, many TRT-focused clinicians target SHBG between 25 and 45 nmol/L. Below 25, free testosterone may spike disproportionately, increasing estradiol conversion and erythrocytosis risk 7. Above 45, even a strong total testosterone of 800, 1 to 000 ng/dL can yield a calculated free testosterone below the symptomatic relief threshold.

For premenopausal women not on oral contraceptives, a functional target of 40, 80 nmol/L is commonly cited by practitioners specializing in female hormonal optimization. Levels below 40 in this group may reflect insulin resistance, polycystic ovary syndrome (PCOS), or metabolic dysfunction. The 2023 international evidence-based PCOS guideline notes that low SHBG is both a marker of and contributor to hyperandrogenism in PCOS, independent of obesity 8.

For postmenopausal women on HRT, SHBG interpretation shifts again. Oral estradiol raises SHBG through hepatic first-pass effect; transdermal estradiol does not 9. A postmenopausal woman on oral estrogen with an SHBG of 95 nmol/L is responding predictably. The same value on transdermal estrogen warrants further workup.

The American Association of Clinical Endocrinology (AACE) 2020 position statement on testosterone therapy notes: "SHBG measurement is essential for accurate assessment of androgen status, particularly in obesity, aging, and diabetes where SHBG is frequently suppressed" 10.

What High SHBG Means Clinically

An SHBG above the functional range reduces bioavailable testosterone and, to a lesser degree, bioavailable estradiol. Symptoms in men may include persistent fatigue, reduced muscle mass, low libido, and cognitive fog despite an apparently adequate total testosterone. Women with elevated SHBG can experience similar androgen-deficiency symptoms: low energy, decreased sexual desire, and thinning hair.

Common causes of elevated SHBG include hyperthyroidism, liver disease (particularly cirrhosis and hepatitis), aging, low caloric intake or very low body fat, oral estrogen administration, and anticonvulsant use 11. Hyperthyroidism is a frequently overlooked driver. Thyroid hormones directly stimulate hepatic SHBG gene transcription. A 2019 study of 1,129 euthyroid adults found that even high-normal free T4 correlated significantly with higher SHBG (beta = 3.4 nmol/L per pmol/L increase in fT4, p < 0.001) 12.

In men with high SHBG and borderline-low free testosterone, the Endocrine Society guideline supports a diagnosis of hypogonadism even when total testosterone is within range 3. This is one of the clearest examples of where relying on the standard total-T range alone leads to missed diagnoses.

High SHBG also complicates TRT monitoring. A man on testosterone cypionate 100 mg/week whose SHBG runs at 60 nmol/L may need a dose adjustment or protocol change (more frequent injections to flatten peaks, or addition of low-dose HCG) to bring his free testosterone into the therapeutic range. Dose titration guided only by total testosterone in this scenario will chronically underdose the patient.

What Low SHBG Means Clinically

Low SHBG (below 20, 25 nmol/L in men, below 30, 40 nmol/L in premenopausal women) amplifies the bioavailability of circulating androgens. In women, this amplification drives hirsutism, acne, and anovulation. In men, it may create a false sense of adequate testosterone status while masking underlying metabolic disease.

Insulin resistance is the single most powerful suppressor of SHBG. A 2009 meta-analysis of 28 cross-sectional studies (N = 15,046) found that each one-unit increase in HOMA-IR was associated with a 14% decrease in SHBG (p < 0.001) 13. The relationship is bidirectional: low SHBG predicts incident type 2 diabetes independently of BMI, fasting glucose, and family history. The prospective Nurses' Health Study and Health Professionals Follow-up Study showed that men in the lowest SHBG quartile had a relative risk of 3.22 for developing type 2 diabetes over 10 years, and women had a relative risk of 4.24 14.

Other causes of low SHBG include hypothyroidism, nephrotic syndrome, exogenous androgen use (including anabolic steroids and high-dose testosterone), growth hormone excess, and glucocorticoid therapy 1.

For men starting TRT with a baseline SHBG below 20 nmol/L, free testosterone can rise disproportionately fast. The clinical implications matter: accelerated aromatization to estradiol, higher hematocrit, and potentially more acne or oily skin. These patients often benefit from lower starting doses, more frequent injection intervals, and closer monitoring of hematocrit and estradiol at weeks 6 and 12.

How to Lower SHBG When It Is Too High

Lifestyle and metabolic interventions form the first line. Because insulin suppresses hepatic SHBG production, interventions that increase insulin signaling (within healthy limits) can bring down an elevated SHBG.

Resistance training is the most consistently supported intervention. A 12-week randomized trial of 44 older men found that progressive resistance training reduced SHBG by 10.8% while increasing free testosterone by 16.2% compared to controls (p = 0.02) 15. The mechanism appears to be improved insulin sensitivity and increased lean mass, both of which shift hepatic SHBG output downward.

Adequate caloric intake matters. Caloric restriction raises SHBG. In men with high SHBG and a BMI below 22, modest caloric surplus (200 to 400 kcal/day with adequate protein at 1.6 g/kg) may help. A 2004 study showed that male athletes who increased caloric intake by 20% saw a 12% decrease in SHBG after 8 weeks 16.

Specific supplements have limited evidence. Boron at 10 mg/day for 7 days decreased SHBG by 9% in a small (N = 8) crossover study of healthy men 17. Magnesium supplementation at 250 mg/day showed a modest inverse correlation with SHBG in a cohort of 399 older men 18. Neither result is strong enough to recommend as monotherapy.

For TRT patients with persistently high SHBG, switching from less-frequent to more-frequent injection protocols (e.g., testosterone cypionate twice weekly instead of once weekly, or daily subcutaneous micro-dosing) produces steadier serum levels and may improve the free-to-total testosterone ratio. Some clinicians also consider very low-dose oral oxandrolone (2.5 to 5 mg/day) off-label specifically to reduce SHBG, though this carries hepatic and lipid risks 19.

Thyroid function should always be checked. Correcting occult hyperthyroidism or reducing a supraphysiologic levothyroxine dose is sometimes the only intervention needed.

How to Raise SHBG When It Is Too Low

Raising SHBG is fundamentally an exercise in improving metabolic health. Weight loss is the most effective intervention. In the Diabetes Prevention Program, participants who lost 7% or more of body weight over 12 months saw SHBG increase by 27% in men and 23% in women 20.

Dietary composition influences SHBG independently of caloric balance. Higher fiber intake is consistently associated with higher SHBG. A cross-sectional analysis of 1,449 men in NHANES found that each 10 g/day increase in fiber intake was associated with a 2.7 nmol/L increase in SHBG after adjustment for BMI and age (p = 0.01) 21.

Coffee consumption shows a dose-dependent positive association with SHBG. In a pooled analysis of four prospective cohorts (N = 10,652), each additional cup of caffeinated coffee per day was linked to a 5 to 6% increase in SHBG 22.

Metformin and GLP-1 receptor agonists raise SHBG primarily through improvements in insulin sensitivity and body composition. In women with PCOS, metformin 1 to 500 mg/day increased SHBG by approximately 30% over 6 months in a meta-analysis of 12 RCTs (N = 1,297) 23. Semaglutide and tirzepatide data specifically on SHBG are emerging; weight-loss-mediated improvements in insulin resistance predict a secondary SHBG rise. The SURMOUNT-1 trial (N = 2,539) with tirzepatide documented improvements in multiple metabolic markers associated with SHBG normalization at 72 weeks 24.

Alcohol reduction helps. Moderate-to-heavy alcohol intake suppresses SHBG through direct hepatotoxic effects and increased free androgen production. Abstinence or reduction often produces a measurable SHBG increase within 4 to 8 weeks.

Interpreting SHBG Alongside Total and Free Testosterone

SHBG should never be interpreted in isolation. The clinical value lives in the ratio and the calculated free testosterone.

The Vermeulen equation (also called the Vermeulen-Sodergard formula) is the most widely validated method for calculating free testosterone from total testosterone, SHBG, and albumin 25. Direct free testosterone assays (analog tracer immunoassays) are unreliable and discouraged by the Endocrine Society, particularly in women and in men with obesity 3.

A practical interpretation framework:

Scenario 1: Total T = 450 ng/dL, SHBG = 55 nmol/L, calculated free T = 6.2 ng/dL. Despite a mid-range total T, free T is below the commonly cited male symptomatic threshold of 7.0 ng/dL. This patient may benefit from therapy or SHBG-lowering strategies.

Scenario 2: Total T = 350 ng/dL, SHBG = 18 nmol/L, calculated free T = 9.1 ng/dL. Total T looks low, but free T is well within range. Investigation should focus on why SHBG is suppressed (insulin resistance, metabolic syndrome) rather than automatically initiating TRT.

Scenario 3: Premenopausal woman, total T = 38 ng/dL, SHBG = 22 nmol/L. Low SHBG amplifies androgen bioavailability. Even though total T is within female reference range (15 to 70 ng/dL), the free androgen index is elevated. Screen for PCOS, insulin resistance, and adrenal androgen excess.

When and How Often to Recheck SHBG

Baseline SHBG should be measured at the initial hormone evaluation. On TRT or HRT, repeat measurement at 6 weeks, 12 weeks, and then every 6 to 12 months alongside hematocrit, PSA (men), and metabolic panel 3. If a lifestyle or pharmacologic intervention specifically targeting SHBG is initiated, recheck at 8 to 12 weeks to confirm direction of change before adjusting hormone doses.

SHBG drawn in the morning (before 10 AM) is preferred because testosterone has a diurnal rhythm and the calculated free T depends on an accurate total T. Fasting is not required for the SHBG assay itself, but concurrent glucose and insulin (for HOMA-IR) require a fasting draw, making a fasting morning sample the most efficient protocol.

Patients on oral estrogen or oral testosterone undecanoate should have SHBG drawn at trough (before the next dose) to avoid measuring a first-pass peak artifact. Transdermal and injectable routes produce less SHBG fluctuation and can be drawn at steady state.